Cargando…
Physician and Patient Barriers to Breast Cancer Preventive Therapy
The uptake of selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) for the primary prevention of breast cancer is low, despite their proven efficacy in several randomized clinical trials. This review summarizes the latest data on physicians’ and women’s barriers to breast ca...
Autores principales: | Hum, Susan, Wu, Melinda, Pruthi, Sandhya, Heisey, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995234/ https://www.ncbi.nlm.nih.gov/pubmed/27617055 http://dx.doi.org/10.1007/s12609-016-0216-5 |
Ejemplares similares
-
Cost of TB prevention and treatment in the Philippines in 2017
por: Capeding, T. P. J., et al.
Publicado: (2022) -
Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer
por: Litzenburger, Beate C., et al.
Publicado: (2014) -
TB/HIV risk factors identified from a General Household Survey of South Africa in 2006
por: Appunni, Sathiya Susuman, et al.
Publicado: (2014) -
Cost of TB services in the public and private sectors in Georgia
por: Chikovani, I., et al.
Publicado: (2021) -
Costs of TB services in India
por: Chatterjee, S., et al.
Publicado: (2021)